Intersection of sex and circadian biology
Current Opinion in Physiology · 2025-09 · 45 · 100834
DOI: 10.1016/j.cophys.2025.100834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Opinion in Physiology, 2025-09. Verfasst von Georgios K Paschos und 2 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The circadian clock aligns behavior and physiology with environmental rhythms, and its disruption has been associated with increased risk of metabolic and neurological diseases. This review examines the emerging trends and mounting evidence demonstrating that there are sex-specific differences in circadian physiology relevant to health. Preclinical and clinical studies indicate that females exhibit greater circadian resilience, robust transcriptional rhythms, and resistance to clock perturbation compared to males. These influences affect susceptibility to metabolic conditions, and responses to circadian perturbations like shift work. Notably, sex differences in response to alcohol consumption and cancer chronotherapy have emerged as fields of significant interest. Future research must consider both sexes to refine existing interventions and uncover the complex mechanisms of circadian physiology for more inclusive therapeutic strategies.
Zitieren
APA
Paschos, G. K., Lordan, R., & FitzGerald, G. A. (2025). Intersection of sex and circadian biology. Current Opinion in Physiology, 45, 100834. https://doi.org/10.1016/j.cophys.2025.100834
Vancouver
Paschos GK, Lordan R, FitzGerald GA. Intersection of sex and circadian biology. Current Opinion in Physiology. 2025;45:100834. doi:10.1016/j.cophys.2025.100834
BibTeX
@article{Paschos2025,
author = {Paschos, Georgios K and Lordan, Ronan and FitzGerald, Garret A},
title = {Intersection of sex and circadian biology},
journal = {Current Opinion in Physiology},
year = {2025},
volume = {45},
pages = {100834},
doi = {10.1016/j.cophys.2025.100834}
}
EUVIMED